ADVENTRX Pharmaceuticals, Inc. (ANX)
$0.10
0.00 (-0.83%)
| CAPS Rating |
|
|---|---|
| Open | $0.10 |
| Previous Close | $0.10 |
| Daily Range | $0.09 - $0.10 |
| 52-Week Range | $0.07 - $0.25 |
| Market Cap | $14.64M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 570,501 |
| Average Daily Volume | 2,600,000 |
ANX
VS S&P 500 (SPY)
This ticker is not currently Ratable.
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
ANX Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
ANX News and Commentary
- Today's 5-Star Movers – The Motley Fool
- Turnaround Time for Biotech? – The Motley Fool
Related News and Articles
- 4 Platform Drugmakers to Invest In – The Motley Fool
- 10 Stocks Shaking the Market – The Motley Fool
- A Big Upgrade for Allos Therapeutics – The Motley Fool
- Now's a Great Time to Invest -- So Don't Blow It Like This – The Motley Fool
- This Stock Is a Train Wreck – The Motley Fool
- Drug Lowers Cholesterol; Stock Follows – The Motley Fool
- The Hottest Sector for 2010 – The Motley Fool
- Abbott: Brave or Stupid? – The Motley Fool
- 5-Star Stocks Poised to Pop: American Oriental Bioengineering – The Motley Fool
- Do You Have the Guts to Buy? – The Motley Fool
- This Top Stock Is a Winner – The Motley Fool
- Amylin Scores a Hat Trick – The Motley Fool
- 10 Stocks Shaking the Market – The Motley Fool
- This Just In: Upgrades and Downgrades – The Motley Fool
- Finally Convinced? Benlysta Works! – The Motley Fool
- Winners and Losers of the House Health-Care Reform Bill – The Motley Fool
RSS Headlines
Fool UK
